Benzinga | Aug 11, 2021 08:20AM EDT

Biomerica Announces Notice Of Allowance For Patent On Product Used To Diagnose And Treat Depression In Japan

Biomerica Inc. (NASDAQ:BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica's first patent pertaining to a revolutionary new treatment option for patients suffering from depression. Specifically, this allowed patent contains broad claims that enables physicians to identify patient specific foods (e.g. salmon, milk, shrimp, broccoli, chickpeas, etc.), that when removed from the patient's diet, may alleviate or improve an individual's depression symptoms.